BioCardia, Inc.
BCDANasdaqCIK 925741HealthcareFiscal year ends Dec 31
Reports and events: 369 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-03-2908:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-008313 |
| 2023-03-2908:15 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001437749-23-008312 |
| 2023-03-0607:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-005465 |
| 2023-02-0106:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-002199 |
| 2023-01-0907:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-23-000689 |
| 2023-01-0907:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-23-000688 |
| 2022-12-2816:07 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-22-130528 |
| 2022-12-2207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-029567 |
| 2022-12-1507:00 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-029106 |
| 2022-12-0607:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-028496 |
| 2022-11-0916:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-22-026593 |
| 2022-11-0916:06 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001437749-22-026591 |
| 2022-10-0309:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-023442 |
| 2022-09-1407:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-022370 |
| 2022-08-3107:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-021534 |
| 2022-08-2407:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-021223 |
| 2022-08-1016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-22-019791 |
| 2022-08-1016:06 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001437749-22-019788 |
| 2022-08-0108:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-018210 |
| 2022-06-1508:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-015015 |
| 2022-06-1016:05 ET | 8-K | 5.07 Shareholder vote results | 0001437749-22-014776 |
| 2022-05-1116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-22-011907 |
| 2022-05-1116:05 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001437749-22-011905 |
| 2022-04-2708:30 ET | DEF 14A | Proxy statementPeriod 2022-06-10 | 0001437749-22-009803 |
| 2022-04-1208:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-008717 |
| 2022-04-1207:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-008711 |
| 2022-03-2916:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-22-007545 |
| 2022-03-2916:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001437749-22-007544 |
| 2022-03-2208:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-006877 |
| 2022-03-0108:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-004767 |
| 2022-02-1408:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-003181 |
| 2022-02-0716:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001085146-22-000569 |
| 2022-02-0308:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-002292 |
| 2021-12-1511:44 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-21-028625 |
| 2021-11-1016:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-21-026171 |
| 2021-11-1016:05 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001437749-21-026143 |
| 2021-10-2109:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-21-024025 |
| 2021-10-1208:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-21-023519 |
| 2021-10-0708:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-21-023406 |
| 2021-09-2209:19 ET | SC 13D | Ownership report, active investor | 0001085146-21-002648 |
| 2021-09-1008:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-21-021870 |
| 2021-08-1208:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-21-019547 |
| 2021-08-1207:33 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001437749-21-019540 |
| 2021-07-1508:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-21-016957 |
| 2021-06-2308:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-21-015420 |
| 2021-06-2208:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-21-015317 |
| 2021-06-2108:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-21-015172 |
| 2021-06-1516:29 ET | 8-K | 5.07 Shareholder vote results | 0001437749-21-014844 |
| 2021-06-1408:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-21-014665 |
| 2021-05-1308:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-21-011924 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 12:20 ET. Listed shows no prices and gives no investment advice.